LAI, ALESSIA
LAI, ALESSIA
Dipartimento di Scienze Biomediche e Cliniche
Epidemiology and molecular analyses of respiratory syncytial virus in the 2021–2022 season in northern Italy
2024 A. Lai, A. Bergna, V. Fabiano, C.D. Ventura, G. Fumagalli, A. Mari, M. Loiodice, G.V. Zuccotti, G. Zehender
Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients
2024 F. Barone, A. Giacomelli, G. Casalini, M. Corbellino, A. Lai, A. Gori, S. Antinori
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease
2024 M. Colaneri, G. Scaglione, F. Fassio, L. Galli, A. Lai, A. Bergna, A. Gabrieli, M. Tarkowski, C.D. Ventura, V. Colombo, L. Cordier, D. Bernasconi, M. Corbellino, G. Dedivitiis, S. Borghetti, D. Visigalli, S. Sollima, G. Casalini, G. Rizzardini, A. Gori, S. Antinori, A. Riva, M. Schiavini
Exploring early COVID-19 therapies, variants, and viral clearance dynamics: Insights from a high-risk outpatients study
2024 M. Colaneri, M. Matone, F. Fassio, A. Lai, A. Bergna, C.D. Ventura, L. Galli, G. Scaglione, A. Gori, M. Schiavini
Serum antibody fingerprinting of SARS-CoV-2 variants in infected and vaccinated subjects by label-free microarray biosensor
2024 T. Carzaniga, L. Casiraghi, G. Nava, G. Zanchetta, T. Inzani, M. Chiari, V. Bollati, S. Epis, C. Bandi, A. Lai, G. Zehender, T. Bellini, M. Buscaglia
Long-Term Effects of SARS-CoV-2 Infection in Hospitalized Children: Findings from an Italian Single-Center Study
2024 V. Calcaterra, V.M. Tagi, E. D'Auria, A. Lai, S. Zanelli, C. Montanari, E. Maria Biganzoli, G. Marano, E. Borghi, V. Massa, A. Riva, G. Zuccotti
Fetal myocarditis associated with maternal SARS-CoV-2 infection
2024 S. Mannarino, M. Lanna, V. Calcaterra, T. Carzaniga, L. Casiraghi, A. Lai, A. Gabrieli, A. Bergna, G. Fini, S. Bianchi, M. De Amici, G. Zehender, T. Bellini, M. Buscaglia, G. Zuccotti
Genomic epidemiology and phylogenetics applied to the study of SARS-CoV-2 pandemic
2023 A. Lai, A. Bergna, C. Della Ventura, G. Zehender
Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2
2023 M. Giovanetti, F. Branda, E. Cella, F. Scarpa, L. Bazzani, A. Ciccozzi, S.N. Slavov, D. Benvenuto, D. Sanna, M. Casu, L.A. Santos, A. Lai, G. Zehender, F. Caccuri, A. Ianni, A. Caruso, A. Maroutti, S. Pascarella, A. Borsetti, M. Ciccozzi
SARS-CoV-2 in freshwaters used for irrigation in the agro-urban environment of Milan (Northen Italy)
2023 M. Tesauro, M. Terraneo, M. Consonni, C. Fappani, M. Gori, D. Colzani, A. Amendola, A. Lai, D. Masseroni, E. Tanzi
The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis and Panoptosis
2023 L. Schifanella, J. Anderson, G. Wieking, P. J Southern, S. Antinori, M. Galli, M. Corbellino, A. Lai, N. Klatt, T. W Schacker, A. T Haase
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021
2023 A. Bergna, A. Lai, C.D. Ventura, B. Bruzzone, A. Weisz, M. D'Avenia, S. Testa, C. Torti, C. Sagnelli, A. Menchise, G. Brindicci, D. Francisci, I. Vicenti, N. Clementi, A. Callegaro, E.V. Rullo, S. Caucci, V. De Pace, A. Orsi, S. Brusa, F. Greco, V. Letizia, E. Vaccaro, G. Franci, F. Rizzo, F. Sagradi, L. Lanfranchi, N. Coppola, A. Saracino, M. Sampaolo, S. Ronchiadin, M. Galli, A. Riva, G. Zehender
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination
2023 I. Varasi, A. Lai, L. Fiaschi, A. Bergna, A. Gatti, B. Caimi, C. Biba, C. Della Ventura, C. Balotta, A. Riva, G. Zehender, M. Zazzi, I. Vicenti
Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination
2023 L. Pezzati, L. Milazzo, G. Carrozzo, C. Kullmann, L. Oreni, M. Beltrami, S. Caronni, A. Lai, L. Caberlotto, C. Ottomano, S. Antinori, A.L. Ridolfo
Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention
2022 B. Caimi, M. Franzetti, R. Velleca, A. Lai, A. Gatti, P.L. Rossi, M. D’Orso, F. Pregliasco, C. Balotta, G. Calicchio
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
2022 A. Lai, B. Caimi, M. Franzetti, A. Bergna, R. Velleca, A. Gatti, P.L. Rossi, M. D’Orso, F. Pregliasco, C. Balotta, G. Calicchio
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes
2022 M. Gori, S. Bianchi, G. Ciceri, A. Lai, M. Tonelli, N. Clementi, M. Clementi, N. Mancini, C. Fappani, G. Zehender, A. Amendola, M. Pontello, E. Tanzi
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
2022 I. Vicenti, F. Dragoni, A. Giannini, A. Casabianca, F. Lombardi, L. Di Sante, O. Turriziani, S. Racca, S. Paolucci, A. Lai, I. Bon, I. Abbate, G. Rozera, S. Belmonti, R. Scutari, C. Alteri, F. Saladini, M. Zazzi
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies
2022 F. Dragoni, E. Schiaroli, V. Micheli, L. Fiaschi, A. Lai, G. Zehender, B. Rossetti, M.R. Gismondo, D. Francisci, M. Zazzi, I. Vicenti
Evidence of SARS-CoV-2 antibodies and RNA on autopsy cases in the pre-pandemic period in Milan (Italy)
2022 A. Lai, S. Tambuzzi, A. Bergna, A. Battistini, C. Della Ventura, M. Galli, R. Zoja, G. Zehender, C. Cattaneo